Get the Stockscreener App
174.81
1.18%
-2.09
After Hours:
175.58
0.77
+0.44%
Overview
News
Price History
Option Chain
Financials
Why ABBV Down?
Discussions
Forecast
Dividend History
Abbvie Inc stock is traded at $174.81, with a volume of 4.87M.
It is down -1.18% in the last 24 hours and down -1.80% over the past month.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
See More
Previous Close:
$176.90
Open:
$176.8
24h Volume:
4.87M
Relative Volume:
0.84
Market Cap:
$308.91B
Revenue:
$55.53B
Net Income/Loss:
$5.12B
P/E Ratio:
60.70
EPS:
2.88
Net Cash Flow:
$15.62B
1W Performance:
+1.27%
1M Performance:
-1.80%
6M Performance:
-5.59%
1Y Performance:
+6.33%
1-Day Range:
$173.73
$177.16
1-Week Range:
$168.06
$177.45
52-Week Range:
$153.58
$207.32
Abbvie Inc Stock (ABBV) Company Profile
Name
Abbvie Inc
Sector
Industry
Phone
(847) 932-7900
Address
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Compare ABBV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
174.81 | 308.91B | 55.53B | 5.12B | 15.62B | 2.88 |
|
LLY
Lilly Eli Co
|
804.99 | 765.07B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
85.19 | 378.21B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
150.38 | 344.63B | 88.82B | 14.07B | 19.03B | 5.79 |
|
MRK
Merck Co Inc
|
97.45 | 251.88B | 63.17B | 12.15B | 14.84B | 4.77 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-24 | Resumed | BofA Securities | Neutral |
| Dec-05-24 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Nov-22-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Nov-04-24 | Upgrade | Argus | Hold → Buy |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Jun-05-24 | Upgrade | HSBC Securities | Hold → Buy |
| May-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-29-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-18-23 | Downgrade | HSBC Securities | Buy → Hold |
| Dec-11-23 | Upgrade | Goldman | Neutral → Buy |
| Nov-09-23 | Initiated | Deutsche Bank | Hold |
| Oct-30-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-20-23 | Resumed | UBS | Neutral |
| Sep-29-23 | Initiated | Raymond James | Outperform |
| Jul-25-23 | Initiated | William Blair | Mkt Perform |
| Jul-14-23 | Initiated | HSBC Securities | Buy |
| Apr-05-23 | Downgrade | Argus | Buy → Hold |
| Mar-01-23 | Initiated | Guggenheim | Buy |
| Feb-22-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-10-23 | Upgrade | SVB Securities | Underperform → Market Perform |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Nov-08-22 | Downgrade | Societe Generale | Buy → Hold |
| Aug-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-23-22 | Initiated | SVB Leerink | Underperform |
| May-06-22 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Apr-06-22 | Resumed | Morgan Stanley | Overweight |
| Feb-28-22 | Downgrade | UBS | Buy → Neutral |
| Feb-03-22 | Reiterated | BMO Capital Markets | Outperform |
| Feb-03-22 | Reiterated | Barclays | Equal Weight |
| Feb-03-22 | Reiterated | BofA Securities | Neutral |
| Feb-03-22 | Reiterated | Goldman | Neutral |
| Jan-13-22 | Initiated | Redburn | Buy |
| Jan-12-22 | Reiterated | BMO Capital Markets | Outperform |
| Dec-09-21 | Resumed | Wells Fargo | Overweight |
| Nov-23-21 | Upgrade | Societe Generale | Hold → Buy |
| Jul-27-21 | Resumed | Truist | Buy |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Jun-23-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jun-09-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Upgrade | Argus | Hold → Buy |
| May-18-20 | Resumed | BofA/Merrill | Neutral |
| May-12-20 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-20 | Resumed | Morgan Stanley | Overweight |
| Apr-20-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Mar-23-20 | Downgrade | Societe Generale | Buy → Hold |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Feb-06-20 | Initiated | Mizuho | Buy |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-26-19 | Reiterated | Cowen | Outperform |
| Sep-26-19 | Upgrade | Citigroup | Neutral → Buy |
| Aug-20-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jun-27-19 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-26-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-28-19 | Initiated | Goldman | Neutral |
| Apr-29-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
View All
Abbvie Inc Stock (ABBV) Latest News
A Glimpse Into The Expert Outlook On AbbVie Through 15 Analysts - Benzinga
AbbVie (NYSE:ABBV) Trading Down 0.1% Following Analyst Downgrade - MarketBeat
AbbVie (NYSE:ABBV) Price Target Lowered to $205.00 at Citigroup - MarketBeat
AbbVie Q4 Earnings Loom: Buy or Sell ABBV Stock Ahead of Results? - Yahoo Finance
BankPlus Wealth Management LLC Makes New Investment in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Court Place Advisors LLC Cuts Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Nilsine Partners LLC Has $1.71 Million Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
I Own 4 High-Yield Dividend Stocks. Here's Why I Own Each One. - The Motley Fool
AbbVie Inc. (NYSE:ABBV) Shares Sold by Pacer Advisors Inc. - MarketBeat
Foundations Investment Advisors LLC Sells 44,138 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Baldwin Wealth Partners LLC MA Lowers Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Mount Yale Investment Advisors LLC Acquires 1,514 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Navigating Market Uncertainty: Intrinsic Value of AbbVie Inc - Yahoo Finance
Summit Financial Strategies Inc. Purchases 4,441 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Webster Bank N. A. Lowers Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Kingswood Wealth Advisors LLC Has $2.19 Million Stake in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Stock Volatile On $200M Deal To Buy Nimble Therapeutics: Retail Still Bearish - MSN
AbbVie's SWOT analysis: biopharma giant navigates post-Humira landscape - MSN
Abbvie seeks molecular glue degraders from Neomorph - BioCentury
AbbVie Defies Market Trends! Investors See Rewarding Gains. - Jomfruland.net
Why AbbVie Stock Popped While the Market Flopped on Monday - MSN
AbbVie (ABBV) Stock Rises Following Analyst Price Target Increas - GuruFocus.com
AbbVie (NYSE:ABBV) Shares Up 2.5%What's Next? - MarketBeat
AbbVie Builds Momentum With Immunology Growth, Goldman Remains PositiveAbbVie (NYSE:ABBV) - Benzinga
Piper Sandler raises AbbVie stock target to $227, keeps Overweight rating - Investing.com India
Do Options Traders Know Something About AbbVie (ABBV) Stock We Don't? - Yahoo Finance
AbbVie A Top Socially Responsible Dividend Stock With 3.9% Yield - Forbes
Cathy Pareto & Associates Inc. Buys Shares of 1,799 AbbVie Inc. (NYSE:ABBV) - MarketBeat
KBC Group NV Boosts Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie a Top 25 Dividend Giant With 3.85% Yield (ABBV) - Nasdaq
Blue Trust Inc. Acquires 8,059 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Has $15.12 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Plaque Psoriasis Market Growth Drivers, Future Innovations and Forecasts 2032 | AbbVie Inc, Novartis - EIN News
Crescent Grove Advisors LLC Purchases 2,696 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Jamison Private Wealth Management Inc. Has $10.35 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Novare Capital Management LLC Has $10.34 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
First Citizens Bank & Trust Co. Sells 1,529 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie: Q4 2024 Earnings Preview And Update On Emraclidine (NYSE:ABBV) - Seeking Alpha
Moody Lynn & Lieberson LLC Has $27.71 Million Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
B.O.S.S. Retirement Advisors LLC Sells 21,638 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
AEGON ASSET MANAGEMENT UK Plc Has $88.51 Million Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Dynamic Advisor Solutions LLC Cuts Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AM Investment Strategies LLC Invests $720,000 in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Gradient Investments LLC Acquires 7,894 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Eclectic Associates Inc. ADV Buys 4,756 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Fifth Third Bancorp Has $260.90 Million Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Is AbbVie Inc. the Hidden Gem in a Bear Market? Find Out Now! - Jomfruland.net
Is AbbVie Inc. (ABBV) The Best Bear Market Stock To Invest In Now? - Insider Monkey
AbbVie Inc. (NYSE:ABBV) Shares Bought by Exchange Traded Concepts LLC - MarketBeat
Sound Income Strategies LLC Buys 9,358 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
MFA Wealth Services Makes New Investment in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Abbvie Inc Stock (ABBV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):